Point of Care Ultrasound Market Report 2025

This report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The point of care ultrasound market size has grown strongly in recent years. It will grow from $4.25 billion in 2024 to $4.58 billion in 2025 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to rise in point-of-care testing, increased clinical utility, compact and portable devices, training and education programs, cost-effectiveness.

The point of care ultrasound market size is expected to see strong growth in the next few years. It will grow to $6.14 billion in 2029 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to integration with artificial intelligence, expanding applications in primary care, global health initiatives, remote and rural healthcare, customization and specialized probes. Major trends in the forecast period include technological advancements, miniaturization and portability, wireless connectivity and cloud integration, expanding applications beyond radiology, remote and rural healthcare access.

The increasing prevalence of chronic diseases is expected to drive the growth of the point-of-care ultrasound (POCUS) market in the coming years. Chronic or non-communicable diseases (NCDs) are long-term health conditions that persist for extended periods and often progress gradually. POCUS is crucial in managing chronic conditions due to its ability to support early detection, enable personalized treatment, and facilitate remote monitoring, ultimately improving patient outcomes. For example, in January 2023, the National Institutes of Health, a US-based government agency, projected that by 2035, 35.66% (within a range of 33.36-36.04) of adults aged 50 and older will have at least one chronic condition, with this figure expected to rise to 47.81% (range: 46.09-49.71) by 2050. Consequently, the growing prevalence of chronic diseases is fueling the growth of the point-of-care ultrasound market.

Major companies in the point-of-care ultrasound market are focused on developing advanced products, such as ultrasound-on-chip technology, to enhance imaging capabilities and drive innovation in medical diagnostics. This technology miniaturizes ultrasound components onto a single chip, making ultrasound devices more compact and portable for various medical imaging applications. It has the potential to increase accessibility to ultrasound diagnostics, with advancements in point-of-care and wearable healthcare devices. For example, in February 2024, Butterfly Network Inc., a US-based manufacturer of medical imaging devices, launched the Butterfly iQ3, the latest version of its handheld point-of-care ultrasound (POCUS) system. The iQ3 incorporates P4.3 ultrasound-on-chip technology, offering the world’s fastest digital data transfer rate. The system is designed to provide enhanced high-resolution imaging, portable ultrasound with advanced 3D capabilities, and double the processing power of its predecessor, the Butterfly iQ+.

In August 2024, Roche Holding AG, a Switzerland-based healthcare company, acquired LumiraDx's Point-of-Care (POC) technology for around $295 million. This acquisition allows Roche to enhance its diagnostics portfolio by integrating LumiraDx's user-friendly platform, which consolidates a broad range of immunoassay and clinical chemistry tests into a single instrument. The move underscores the increasing demand and interest in accessible POC analysis systems within the healthcare sector. LumiraDx, a UK-based company, specializes in developing point-of-care diagnostic tools and devices, including ultrasound devices for various health conditions.

Major companies operating in the point of care ultrasound market report are Samsung Electronics Co. Ltd., Hitachi Ltd., Siemens Healthineers GmbH, Fujifilm Holdings Corporation, Becton, Dickinson, and Company, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Toshiba Medical Systems Corporation, Fukuda Denshi Co. Ltd., FUJIFILM Sonosite Inc., Analogic Corporation, B. Braun SE, Esaote SPA, Bard Access Systems Inc., Zimmer MedizinSysteme GmbH, Chison Medical Imaging Co. Ltd., Butterfly Network Inc., Terason Division Teratech Corporation, Advanced Instrumentations, DRE Medical, ALPINION Medical Systems Co. Ltd., Shenzhen AnaSonic Bio-Medical Technology Co. Ltd., Healcerion Co. Ltd., Edan Instruments Inc., Shenzhen Landwind Industry Co. Ltd., Teknova Medical Systems Co. Ltd.

North America was the largest region in the point of care ultrasound market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the point of care ultrasound market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the point-of-care ultrasound market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The point-of-care ultrasound market consists of sales of handheld ultrasound scanners, ultrasound transducers, ultrasound gel, accessories and consumables, and vascular access ultrasound guidance kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

Point-of-care ultrasound (POCUS) involves the utilization of portable ultrasound devices at the bedside or in a clinical setting for immediate diagnostic and therapeutic purposes. This approach provides several advantages, including real-time assessment, immediate feedback, and the potential to expedite clinical decision-making.

Point-of-care ultrasound encompasses two main types, diagnostic devices and therapeutic devices. Diagnostic devices are medical instruments or tools specifically crafted to aid healthcare professionals in identifying and confirming the presence of diseases, conditions, or abnormalities in a patient. These devices come in various portability options, including trolley-based and handheld devices. They find applications in diverse medical fields such as emergency medicine, cardiology, obstetrics and gynecology, urology, vascular surgery, and musculoskeletal care. Additionally, they are utilized by various end-users including hospitals, clinics, maternity centers, ambulatory surgical centers, and other healthcare facilities.

The point-of-care ultrasound market research report is one of a series of new reports that provides a point of care ultrasound market statistics, including point of care ultrasound industry global market size, regional shares, competitors with a point-of-care ultrasound market share, detailed point of care ultrasound market segments, market trends and opportunities, and any further data you may need to thrive in the point of care ultrasound industry. This point-of-care ultrasound market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.